Anno: 1993

• Titolo: Selective effect of melatonin on the proliferation of lymphoid cells
  Riferimento:

  Int J Biochem. 1993 Mar;25(3):441-4.
  Azione della melatonina:

  Mlt (200 microM) affect selectively the processes of lymphoblastoid cell growth.
  Target:

  Inhibition of [3H]thymidine incorporation.
• Titolo: Breast cancer and electric power
  Riferimento:

  Biomed Pharmacother. 1993;47(10):435-8. Review.
  Azione della melatonina:

  These can reduce nocturnal melatonin production.
  Target:

  Light-at-night/electromagnetic fields
• Titolo: Electromagnetic fields and male breast cancer
  Riferimento:

  Biomed Pharmacother. 1993;47(10):425-7. Review
  Azione della melatonina:

  Pineal function is suppressed by light-at-night(LAN) 60-Hz electric fields suppress the nocturnal rise in pineal melatonin production.
  Target:

  Electromagnetic fields Light-at-night
• Titolo: Selective effect of melatonin on the proliferation of lymphoid cells
  Riferimento:

  Int J Biochem. 1993 Mar;25(3):441-4.
  Azione della melatonina:

  Affect selectively the processes of lymphoblastoid cell growth.
  Target:

  200 microM in vitro.
• Titolo: Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract
  Riferimento:

  Br J Cancer.1993 Jun;67(6):1404-7.
  Azione della melatonina:

  The immunotherapy with low-dose IL-2 plus MLT (50mg/day orally) is a new well tolerated and effective therapy of advanced tumours of digestive tract.
  Target:

  Interleukin 2 (IL-2) plus MLT.
• Titolo: Vitiligo: where do we stand?
  Riferimento:

  Pigment Cell Res. 1993 Mar;6(2):61-72.
  Azione della melatonina:

  Abnormalities in a putative melatonin receptor on melanocytes.
  Target:

  Several different pathogenetic mechanisms.
• Titolo: Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
  Riferimento:

  Eur J Cancer. 1993;29A(2):185-9.
  Azione della melatonina:

  Neuroimmunotherapy with low-dose IL-2 and MLT (50mg/day orally) is a biologically active and well tolerated strategy, capable of determining an apparent control of tumour growth in patients with advanced solid neoplasms.
  Target:

  Interleukin 2 (IL-2) plus .MLT
• Titolo: [Melatonin, a clinically important hormone?]
  Riferimento:

  Dtsch Med Wochenschr. 1983 Mar 25;108(12):470-4. Review.
  Azione della melatonina:

  No abstract available.
  Target:

  No abstract available.
• Titolo: Biologically based epidemiological studies of electric power and cancer
  Riferimento:

  Environ Health Perspect. 1993 Dec;101 Suppl 4:93-100.
  Azione della melatonina:

  Effects on: DNA transcription and translation, calcium balance in cells, pineal production of mlt.
  Target:

  Electromagnetic fields (EMF)
• Titolo: Melatonin modulation of estrogen-receptor expression in mcf-7 human breast-cancer cells
  Riferimento:

  Int J Oncol. 1993 Oct;3(4):687-94.
  Azione della melatonina:

  Antimitotic actions of melatonin(10(-8)-10(-11) M) may be mediated through the suppression of the estrogen-response pathway of MCF-7 cells.
  Target:

  Estrogen receptor (ER)